Sabapathy, S. (2018) “COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA”, Journal of Population Therapeutics and Clinical Pharmacology, 23(2). Available at: https://mail.jptcp.com/index.php/jptcp/article/view/206 (Accessed: 19 November 2024).